You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Single or recurrent

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cervical Cancer Trial (Nimotuzumab?Tislelizumab)

Not yet recruiting
  • Cervical Cancer
  • (no location specified)
Sep 9, 2023

Adult Trial in Zhengzhou (GT101)

Recruiting
  • Adult
  • GT101
  • Zhengzhou, Henan, China
    The First Affiliated Hospital of Zhengzhou University
Oct 11, 2023

Colon Cancer Trial in Qingdao (Chimeric antigen receptor T cell preparation targeting GCC)

Recruiting
  • Colon Cancer
  • Chimeric antigen receptor T cell preparation targeting GCC
  • Qingdao, Shandong, China
    The Affiliated Hospital of Qingdao University
May 16, 2023

Clostridium Difficile, Ulcerative Colitis Trial in Rome (single FMT, sequential FMT)

Recruiting
  • Clostridium Difficile
  • Ulcerative Colitis
  • single FMT
  • sequential FMT
  • Rome, Italy
    Digestive Disease Center, Fondazione Policlinico Univesitario A.
Oct 5, 2023

Head Neck Cancer, Recurrent Cancer Trial in Guangzhou (Penicillamine)

Not yet recruiting
  • Head and Neck Cancer
  • Recurrent Cancer
  • Guangzhou, Guangdong, China
    Southern medical university
Oct 24, 2023

Cervical Cancer Recurrent Trial in Beijing (RC48 + Tislelizumab)

Recruiting
  • Cervical Cancer Recurrent
  • RC48 + Tislelizumab
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Sep 25, 2023

Nasopharyngeal Carcinoma, Immune Checkpoint Inhibitors Trial (Cadonilimab, Gemcitabine, Cisplatin)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Immune Checkpoint Inhibitors
  • (no location specified)
Jun 1, 2023

Tislelizumab Combing Chemoradiotherapy in Recurrent Cervical

Recruiting
  • Cervical Cancer
  • +2 more
  • Treatment Group
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
May 9, 2023

Solid Tumors, Adult Trial in Xuzhou (TIL injection)

Recruiting
  • Solid Tumors, Adult
  • TIL injection
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital Of Xuzhou Medical University
Oct 12, 2023

Recurrent Liver Cancer After Liver Transplantation Trial (Hepatic arterial infusion chemo + Atezolizumab and bevacizumab)

Not yet recruiting
  • Recurrent Liver Cancer After Liver Transplantation
  • Hepatic arterial infusion chemotherapy + Atezolizumab and bevacizumab
  • (no location specified)
Apr 17, 2023

Langerhans Cell Histiocytosis, LCH Trial (FCN-159)

Not yet recruiting
  • Langerhans Cell Histiocytosis
  • LCH
  • (no location specified)
Aug 15, 2023

Recurring Glioblastoma Trial in Fujian (Recombinant L-IFN adenovirus injection)

Recruiting
  • Recurring Glioblastoma
  • Recombinant L-IFN adenovirus injection
  • Fujian, Fujian, China
    Binhai Hospital of Fujian Medical University
Jun 27, 2023

Recurrent Urinary Tract Infection, Genitourinary Syndrome of Menopause Trial in London (Deka SmartXide Touch C60 (MonaLisa

Recruiting
  • Recurrent Urinary Tract Infection
  • Genitourinary Syndrome of Menopause
  • Deka SmartXide Touch C60 (MonaLisa Touch)
  • Sham
  • London, United Kingdom
    King's College Hospital
Nov 6, 2023

Ovarian Cancer, Malignant Tumor of Uterus Trial in New York (Sacituzumab, Cisplatin)

Not yet recruiting
  • Ovarian Cancer
  • Malignant Neoplasm of Uterus
  • New York, New York
    Icahn School of Medicine at Mount Sinai Division of Hematology a
Sep 14, 2023

Lung Cancer Stage IV Trial in Maastricht (Radiation)

Not yet recruiting
  • Lung Cancer Stage IV
  • Radiation
  • Maastricht, Netherlands
    Maastricht Radiation Oncology (Maastro)
Aug 29, 2023

Ovarian Tumors, Ovarian Diseases Trial (Adebrelimab, Fuzuloparib)

Not yet recruiting
  • Ovarian Neoplasms
  • Ovarian Diseases
  • (no location specified)
Feb 23, 2023

Recurrent Vulvar Cancer, Persistent Vulvar Cancer, Metastatic Vulva Cancer Trial (Pembrolizumab, Lenvatinib)

Not yet recruiting
  • Recurrent Vulvar Cancer
  • +3 more
  • (no location specified)
Jun 12, 2023

Bladder Cancer Trial in Tianjin (Cadonilimab)

Recruiting
  • Bladder Cancer
  • Tianjin, Tianjin, China
    Tianjin Medical University Second Hospital
Aug 23, 2023

Recurrent Rectal Cancer Trial in Shanghai (PD-1 antibody, Capecitabine, Oxaliplatin)

Not yet recruiting
  • Recurrent Rectal Cancer
  • PD-1 antibody
  • +3 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 17, 2022

Carcinoma; Hepatocellular Trial (Stereotactic body radiation therapy)

Not yet recruiting
  • Carcinoma; Hepatocellular
  • Stereotactic body radiation therapy
  • (no location specified)
Oct 26, 2022

Arrhythmia Burden in Patients With Recurrent, Paroxysmal Atrial Fibrillation Despite Durable Pulmonary Vein Isolation Trial in

Not yet recruiting
  • Arrhythmia Burden in Patients With Recurrent, Paroxysmal Atrial Fibrillation Despite Durable Pulmonary Vein Isolation
  • Renal Denervation
  • Basel, Switzerland
  • +1 more
Apr 4, 2023

Ventricular Tachycardia Trial in Zürich (Dose escalating stereotactic arrhythmia radioablation to treat ventricular tachycardia

Recruiting
  • Ventricular Tachycardia
  • Dose escalating stereotactic arrhythmia radioablation to treat ventricular tachycardia (VT)
  • Zürich, Zurich, Switzerland
    University Hospital Zurich
Oct 21, 2022

Clostridium Difficile Infection Recurrence Trial in North Little Rock, Shreveport (RBX2660)

Recruiting
  • Clostridium Difficile Infection Recurrence
  • North Little Rock, Arkansas
  • +1 more
Apr 27, 2023

Recurrent Nasopharyngeal Carcinoma Trial (endoscopic surgery)

Not yet recruiting
  • Recurrent Nasopharyngeal Carcinoma
  • endoscopic surgery
  • (no location specified)
Jun 22, 2022

Gynecologic Cancer, Carcinoma, Uterine Cancer Trial in Birmingham (Cabo + Dostarlimab)

Not yet recruiting
  • Gynecologic Cancer
  • +3 more
  • Cabo + Dostarlimab
  • Birmingham, Alabama
    O'Neal Comprehensive Cancer Center at UAB
Jan 10, 2023